Topics

AmerisourceBergen Reports Fiscal 2019 Second Quarter Results

06:30 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Revenues of $43.3 billion for the Second Quarter, a 5.6 Percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $0.13 and Adjusted Diluted EPS of $2.11 Adjusted Diluted EPS Guidance Range Rais...

Other Sources for this Article

Bennett S. Murphy
Vice President, Investor Relations
610-727-3693
bmurphy@amerisourcebergen.com

NEXT ARTICLE

More From BioPortfolio on "AmerisourceBergen Reports Fiscal 2019 Second Quarter Results"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...